Medivation Inc - Strategic SWOT Analysis Review
Medivation Inc - Strategic SWOT Analysis ReviewSummary
Medivation Inc (Medivation), a subsidiary of Pfizer is a biopharmaceutical company which develops and commercializes medically innovative therapies to treat serious diseases. The company’s product Xtandi is developed for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). The company with collaboration with Astellas conducts studies for the treatment of enzalutamide in prostate cancer, advanced breast cancer and hepatocellular carcinoma.
GlobalData's Medivation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.
Medivation Inc Key Recent Developments:
Aug 09,2016: Medivation Reports Second Quarter 2016 Financial Results
Jul 05,2016: Sanofi Enters Into Confidentiality Agreement With Medivation And Will Be Provided Due Diligence Access And Confidential Information
Jun 13,2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation’s Board
Jun 01,2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation’s Board of Directors
May 27,2016: Medivation Files Preliminary Consent Revocation Statement
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - GlobalData's summarization of the company's business strategy.
- SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Note: Some sections may be missing if data is unavailable for the company.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.